Tag Archives: biib

Biogen, Gilead, Celgene Drugs Get Thumbs Up In Europe

Top-rated biotechs Biogen Idec, Gilead Sciences and Celgene all got good news from Europe Friday, sending their stocks to all-time highs. Biogen’s (BIIB) multiple sclerosis drug Tecfidera moved a step closer to launch in the European Union after it was ruled as a “new active substance” by the EU’s Committee for Medicinal Products for Human Use (CHMP). Under EU rules, a new active substance can be protected from competition for 10

Biogen Wins EU Exclusivity Fight; Stock Soars

Biogen Idec’s (BIIB) multiple-sclerosis drug Tecfidera moved a step closer to launch in the European Union Friday after Biogen won a long-fought battle for market exclusivity. Biogen stock jumped more than 10% in early trading in the stock market today, to an all-time high near 278. Tecfidera, which was launched in the U.S. earlier this year, got a positive panel vote in Europe in March, but Biogen then pushed back its launch date while it